Brain Energy Metabolism in Alzheimers Disease - Part B
- 1st Edition, Volume 187 - August 1, 2026
- Latest edition
- Editor: Subashchandrabose Chinnathambi
- Language: English
Brain Energy Metabolism in Alzheimer’s Disease – Part B, Volume 187 in the International Review of Neurobiology series, presents current advances and comprehensive reviews on met… Read more
Description
Description
Brain Energy Metabolism in Alzheimer’s Disease – Part B, Volume 187 in the International Review of Neurobiology series, presents current advances and comprehensive reviews on metabolic dysfunction in neurodegenerative diseases. This volume brings together contributions from an international panel of experts, focusing on the molecular and cellular mechanisms underlying energy imbalance in Alzheimer’s disease and related disorders.
Chapters in this release explore key processes such as autophagy and ESCRT pathways, tau modifications, insulin resistance, and mitochondrial dysfunction. Additional sections examine neurovascular–glial interactions, genetic and epigenetic factors in neurodegeneration, and the roles of metallospecies, noncoding RNAs, and phase separation in disease progression.
Further contributions address neuroprotective signaling pathways, metabolic impairments in glucose and lipid homeostasis, and emerging diagnostic and therapeutic approaches, including liquid biopsy markers and targeted metabolic interventions. Together, these chapters provide an integrated overview of the mechanisms, biomarkers, and therapeutic opportunities associated with brain energy metabolism in neurodegenerative diseases, making this volume an essential reference for researchers and clinicians in neuroscience and neurobiology.
Key features
Key features
- Presents current advances in brain energy metabolism and neurodegenerative disease research
- Includes contributions from leading experts in neuroscience, neurobiology, and metabolic biology
- Covers molecular, cellular, and systemic mechanisms underlying metabolic dysfunction in Alzheimer’s disease
- Explores emerging biomarkers, diagnostic tools, and therapeutic strategies
- Serves as an essential reference for researchers, clinicians, and graduate students
Readership
Readership
Table of contents
Table of contents
Part B
- Role of ESCRT Pathway and Autophagy in Neurodegenerative Diseases
- Bioenergetic Impairment-Induced Tau Acetylation: Converging Pathways in Alzheimer’s Disease
- Insulin Resistance and Obesity: Drivers of Energy Crisis for Alzheimer’s Disease
- Therapeutic Targeting of Brain Bioenergetics in Alzheimer’s Disease: Addressing Insulin Resistance, Glucose Hypometabolism, and Mitochondrial Dysfunction
- Neurovascular–Glia Crosstalk in the Alzheimer’s–Delirium Nexus: Molecular Mechanisms and Therapeutic Repurposing
- Genetic and Epigenetic Complexity of Parkinson’s Disease: From Dopamine Pathways to Estrogen Interplay
- Metallospecies and Their Biological Functions in Alzheimer’s Disease
- Liquid–Liquid Phase Separation of Tau in Alzheimer’s Disease
- Noncoding RNA and Receptor Tyrosine Kinase-Mediated Regulation of Brain Energy Metabolism Dysfunction in Alzheimer’s Disease
- Activation of Nrf2 Neuroprotective Pathways for Treatment of Parkinson’s Disease: A State-of-the-Art Review
- Metabolic Drivers of Alzheimer’s Disease Pathogenesis: Impairments in Glucose Utilization, Lipid Homeostasis, and Alternative Substrate Metabolism
- Glial Molecular Signatures as a Liquid Biopsy Marker in Alzheimer’s Disease Diagnosis
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 187
- Published: August 1, 2026
- Language: English
About the editor
About the editor
SC
Subashchandrabose Chinnathambi
Subashchandrabose Chinnathambi is Additional Professor at the Department of Neurochemistry, National Institute of Mental Health and Neurosciences Hospital Bangalore, Karnataka, India. His scientific interests include physiopathology of neurodegenerative disorders, Tau Cytoskeleton, Tau-GPCR, purinergic and chemokine receptors, Tau stem cells, animal models, neuropharmacology, therapeutic approaches targeting Tau oligomers, and biomarkers for neurodegeneration. He serves on the editorial board for various international cell biology journals and is also a regular invited speaker at a number of meetings and workshops. Dr. Chinnathambi has more than 16 years of research experience in the area of neuroscience and Tau-related research in Alzheimer’s Disease.